Stock Market News in real time

Biotech firms Redx Pharma and Jounce Therapeutics to combine business

February 23, 2023 at 02:33 am EST

(Reuters) - British biotech firm Redx Pharma plc and U.S.-based Jounce Therapeutics Inc will merge to create an entity specialised in small molecule-targeted therapeutics and antibody drug discovery to treat cancer and fibrotic disease.

The all-share merger deal will create a new company called Redx Inc and will be listed on Nasdaq, the companies said on Thursday.

(Reporting by Radhika Anilkumar in Bengaluru; Editing by Sohini Goswami)

Stocks mentioned in the article

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Price	Change	5d. change	Capi.
REDX PHARMA PLC	15 GBX	+31.58%	-.--%	70.6M
JOUNCE THERAPEUTICS, INC.	1.88 USD	-2.59%	-.--%	98.96M
NASDAQ COMPOSITE	16,833 PTS	+0.22%	+1.95%	-

Headlines

The latest transactions by star managers

The beauty market has it all

May 20, 2024 at 05:19 am EDT

Oil executives to host Trump fundraiser in Houston

May 21, 2024 at 04:26 pm EDT

First Canadian oil export cargo from expanded Trans Mountain pipeline set to load

May 21, 2024 at 04:25 pm EDT

TSX squeaks out record high as resource shares climb

May 21, 2024 at 04:23 pm EDT

News Highlights : Top Energy News of the Day - Tuesday at 4 PM ET

May 21, 2024 at 04:16 pm EDT

CBOT wheat hits July high on declining Russian crop estimates

May 21, 2024 at 03:40 pm EDT

Dollar firm as Fed officials urge patience on rate cuts

May 21, 2024 at 03:30 pm EDT

Wheat Futures Rise on Black Sea Weather Impact -- Daily Grain Highlights

May 21, 2024 at 03:27 pm EDT

News Highlights : Top Global Markets News of the Day - Tuesday at 3 PM ET

May 21, 2024 at 03:16 pm EDT

All our articles

Stock Market News in real time

Biotech firms Redx Pharma and Jounce Therapeutics to combine business

Stocks mentioned in the article

Headlines

Most Read News